Australia's most trusted
source of pharma news
Saturday, 21 December 2024
Posted 1 October 2024 PM
Gilead Sciences has officially opened a second round of grants for community and patient organisations working in certain cancers and blood-borne viruses across Australia with an additional $140,000 on the table.
The Community Grants Program is focused on improving equity in access to care for Australians. Organisations focused in the areas of HIV, viral hepatitis, blood and breast cancer are encouraged to apply for grants up to $50,000.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.